Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Logan Kilpatrick has become the public face of Google's AI offensive, and, intentionally or not, a one-man marketing machine.

Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial ...

Google DeepMind has officially launched Gemma 3n, the latest version of its lightweight generative AI model designed ...

Google DeepMind has officially launched Gemma 3n, the latest version of its lightweight generative AI model designed ...

NOAA will be collaborating with Google's DeepMind and will evaluate the new models and provide feedback to Google's AI ...

Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Imagine a world without disease. Sounds utopian? AI just made it a multibillion-dollar bet to discover drugs – and forget Big ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

For a company long defined by proprietary development, this move is a symbol of a broader technological undercurrent sweeping ...

A public feud over model originality threatens China’s collaborative AI front, with Huawei denying whistleblower claims of ...